PI(s): Thomas Chatzikonstantinou, Andreas Agathangelidis
Short description:
This is an international retrospective, observational study with a cohort study design.
This study aims to explore differences in the outcomes of patients with CLL belonging to subset #2
in a real-world setting.
Objectives:
Primary objective:
-
To determine the event-free survival (EFS) (events: death & next treatment)
of patients with CLL belonging to stereotyped subset #2 for each type of treatment
Secondary objectives:
- To assess the response for each type of treatment (2018 iwCLL criteria)
- To evaluate Richter transformation for each type of treatment
- To determine the OS of patients treated with different treatment types
- To perform multivariate analyses to identify risk factors for event-free survival
Contact:
eric-clldb.inab@certh.gr,
thomas.chatzikonstantinou@certh.gr
